
Ajay Singh Kumar
About Ajay Singh Kumar
Data last updated:
Ajay Singh Kumar has 9 years in corporate governance. Holds Non- Individual Subscriber role. Currently with 2 companies, including Ekimora Technologies Private Limited and Xantium Rx Technologies Private Limited. Formerly with 1 company, such as Azurity Pharmaceuticals India Llp. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Non- Individual Subscriber | 06 Aug 2026 | 2026 | – | Active | |
| Non- Individual Subscriber | 28 Jul 2026 | 2026 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 24 May 2017 | 2017 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajay Singh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajay Singh Kumar
Ajay Singh Kumar has 9 years in corporate governance. Holds Non- Individual Subscriber role. Currently with 2 companies, including Ekimora Technologies Private Limited and Xantium Rx Technologies Private Limited. Formerly with 1 company, such as Azurity Pharmaceuticals India Llp. Engaged in Technology, General Business. Contributes to corporate operations.
Ajay Singh Kumar is associated with 2 companies as Non- Individual Subscriber, including Xantium Rx Technologies Private Limited, Ekimora Technologies Private Limited.
Ajay Singh Kumar has expertise in Technology, General Business.
Ajay Singh Kumar has 9 years in corporate governance.
Ajay Singh Kumar currently holds positions at 2 companies: Xantium Rx Technologies Private Limited, Ekimora Technologies Private Limited.